Science Translational Medicine

ISSN: 1946-6234

Journal Home

Journal Guideline

Science Translational Medicine Q1 Unclaimed

American Association for the Advancement of Science United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Science Translational Medicine is the leading weekly online journal publishing research at the intersection of science, engineering and medicine. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers from all established and emerging disciplines relevant to medicine It has an SJR impact factor of 6,361.

Science Translational Medicine focuses its scope in these topics and keywords: m, h, cell, n, il, f, j, therapy, immune, gene, ...

Type: Journal

Type of Copyright:


Open Access Policy: Non Open Access

Type of publications:

Publication frecuency: -


- €

Inmediate OA

- €

Embargoed OA

900 €

Non OA


Science Translational Medicine


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)




No comments ... Be the first to comment!

Aims and Scope

m, h, cell, n, il, f, j, therapy, immune, gene, tumor, response, targeting, translational, mahil, article, barker, ciccarelli, ahlfors, individuals, peakman, genes, p, mutations, meglio, human, k, knockout, ilrl, carr, disease, catapano,

Best articles by citations

Ovarian Cancer Going Viral

View more

Spreading Aches

View more

Peer-to-Peer Sharing Spurs Scientific Innovation

View more

Nurturing the Impulse to Supersize

View more

What's old is new again: Autologous stem cell transplant for AMD

View more

Training Translators for Smart Drug Discovery

View more

Stopping a Mutant Kinase in Its Tracks

View more

Too Much of a Good Thing

View more

Measuring thePlasmodium falciparumHRP2 protein in blood from artesunate-treated malaria patients predicts post-artesunate delayed hemolysis

View more

Giving Tumors the Silent Treatment

View more

Let There Be Light: Next-Generation Artificial Corneas

View more

Genetic Polymorphisms: A Cornerstone of Translational Biobehavioral Research

View more

Monitoring Methylation

View more

Some Rozi for CF Too!

View more

Retinal Stem Cells: Eye Know Where to Go

View more

Science Translational Medicine Podcast: 7 April 2010

View more

Statistical Challenges in the Evaluation of Treatments for Small Patient Populations

View more

Fishermen and Farmers Share SNPs and Severe Fibrosis

View more

Efficacy of Cetuximab in the Treatment of Menetrier's Disease

View more

Safety and Efficacy of Subretinal Readministration of a Viral Vector in Large Animals to Treat Congenital Blindness

View more

Moms and the Metabolic Syndrome

View more

Klf15 Deficiency Is a Molecular Link Between Heart Failure and Aortic Aneurysm Formation

View more

Playing Without Pain--Or Tumors

View more

A BRCA3 Gene?

View more